Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Seattle Genetics Sees FY21 ADCETRIS Sales $675M-$700M, Sees PADCEV Sales $310M-$325M, Sees TUKYSA Sales $300M-$315M, Sees Royalty Sales $125M-$135M


Benzinga | Jul 29, 2021 04:17PM EDT

Seattle Genetics Sees FY21 ADCETRIS Sales $675M-$700M, Sees PADCEV Sales $310M-$325M, Sees TUKYSA Sales $300M-$315M, Sees Royalty Sales $125M-$135M






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC